Title:
USE OF METFORMIN SALT IN TREATING CEREBRAL INFARCTION
Document Type and Number:
WIPO Patent Application WO/2019/120111
Kind Code:
A1
Abstract:
Provided in the present invention is a use of a metformin salt, in particular metformin monothreonate, in preparing a drug for treating cerebral infarctions. The metformin monothreonate of the present invention has an excellent effect in treating cerebral infarctions. Also provided in the present invention are a preparation method and a composition of metformin monothreonate.
Inventors:
ZHEN XUECHU (CN)
LIU ZONGYIN (CN)
QIAN LINYI (CN)
CAO HUIMIN (CN)
LIU ZONGYIN (CN)
QIAN LINYI (CN)
CAO HUIMIN (CN)
Application Number:
PCT/CN2018/120479
Publication Date:
June 27, 2019
Filing Date:
December 12, 2018
Export Citation:
Assignee:
ZHEN XUECHU (CN)
International Classes:
A61K31/60; A61K38/00; A61P9/10
Foreign References:
| CN102093261A | 2011-06-15 |
Other References:
YU YONGFEI ET AL.: "Clinical study of thrombolytic therapy with intravenous recombinant tissue-type plasminogen activator for patients with acute cerbral infraction", JOURNAL OF CRITICAL CARE IN INTERNAL MEDICINE, vol. 20, no. 4, 15 August 2014 (2014-08-15), pages 244 - 245
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF:
Previous Patent: IMAGE RECONSTRUCTION METHOD AND DEVICE
Next Patent: USE OF MIMETIC ANTIGEN COMPOUND FOR TREATING SYMPTOMS RELATED TO HBV INFECTIONS
Next Patent: USE OF MIMETIC ANTIGEN COMPOUND FOR TREATING SYMPTOMS RELATED TO HBV INFECTIONS